Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 5Breast 2Genitourinary 1

Conditions

Urologic Diseases 1Renal Insufficiency 1Neoplasms 1Kidney Neoplasms 1Kidney Diseases 1Hypothermia 1Carcinoma, Renal Cell 1

Interventions

Docetaxel 390pembrolizumab 325Prednisone 285Gemcitabine 273enzalutamide 256Radiotherapy 251Nivolumab 248Magnetic Resonance Spectroscopy 247Cisplatin 209Abiraterone Acetate 198Radiosurgery 184Leuprolide 182Sunitinib 169Carboplatin 161bicalutamide 148Goserelin 145Androgen Antagonists 142Specimen Handling 138Ipilimumab 128Paclitaxel 125Cyclophosphamide 116acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 110Bevacizumab 109Everolimus 107apalutamide 99abiraterone 99cabozantinib 98atezolizumab 97Sorafenib 97Radiation 89

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Ice × Genitourinary × Clear all
NCT01529658 2016-10-27

Renal Hypothermia During Partial Nephrectomy

Ottawa Hospital Research Institute

Phase NA Unknown
184 enrolled
Genitourinary

Carcinoma, Renal Cell, Hypothermia, Kidney Diseases, Kidney Neoplasms, Neoplasms, Urologic Diseases, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡